ArticleLeukemia2017
Targeting BET proteins improves the therapeutic efficacy of BCL-2 inhibition in T-cell acute lymphoblastic leukemia.
S Peirs et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
37 papers cite it
this paperpooled itcites it